SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149) (BIVI) — Jun 28, 2019

BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149)
Date: June 28, 2019 · CIK: 0001580149 · Accession: 0001520138-19-000210

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-231136

Referenced dates: May 7, 2019

Date
June 28, 2019
Author
Terren Peizer
Form
CORRESP
Company
BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149)

Letter

Securities and Exchange Commission Registration Statement on Form S-1 Filed April 30, 2019 File No. 333-231136

Re: BioVie Inc.

Dear Ms. Westbrook:

BioVie Inc. (the “Company”) hereby provides responses (the “Response Letter”) to a comment issued in a letter dated May 7, 2019 (the “Staff Letter”) regarding the Company’s Registration Statement on Form S-1 filed April 30, 2019 (the “Registration Statement”).

In order to facilitate the review by the staff of the Securities and Exchange Commission (the “Staff”) of the Response Letter the numbered paragraph set forth below corresponds to the numbered paragraph in the Staff Letter.

Registration Statement on Form S-1 filed on April 30, 2019

Cover page

1. We note your disclosure of a recent sale price of your common stock on the OTCQB Marketplace. Please expand your disclosure to state the expected offering price per share or method by which the offering price will be determined. Refer to Instruction 2 to Item 501(b)(3) of Regulation S-K.

COMPANY RESPONSE: Concurrently with the submission of this response, the Company is filing an amendment on Form S-1/A containing the disclosures described in the Staff’s comment.

Please let me know if the Staff has any further questions or concerns with respect to the Registration Statement.

Sincerely,
Terren Peizer

Show Raw Text
CORRESP
1
filename1.htm

June 28, 2019

Christine Westbrook

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 Re: BioVie Inc.

Registration Statement on Form S-1

Filed April 30, 2019

File No. 333-231136

Dear Ms. Westbrook:

BioVie Inc. (the “Company”)
hereby provides responses (the “Response Letter”) to a comment issued in a letter dated May 7, 2019 (the “Staff
Letter”) regarding the Company’s Registration Statement on Form S-1 filed April 30, 2019 (the “Registration
Statement”).

In order to facilitate the review by
the staff of the Securities and Exchange Commission (the “Staff”) of the Response Letter the numbered paragraph
set forth below corresponds to the numbered paragraph in the Staff Letter.

Registration Statement on Form
S-1 filed on April 30, 2019

Cover page

 1. We note your disclosure of a recent sale price
of your common stock on the OTCQB Marketplace. Please expand your disclosure to state the expected offering price per share or
method by which the offering price will be determined. Refer to Instruction 2 to Item 501(b)(3) of Regulation S-K.

COMPANY RESPONSE: Concurrently with
the submission of this response, the Company is filing an amendment on Form S-1/A containing the disclosures described in the Staff’s
comment.

Please let me know if the Staff has any further questions
or concerns with respect to the Registration Statement.

Sincerely,

Terren Peizer

Chairman and Chief Executive Officer

CC:	Mitchell S. Nussbaum, Esq.